Drug and Alcohol Dependence

Article	Citations
Signal of increased opioid overdose during COVID-19 from emergency medical services data	313
The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017	214
Alcohol and other substance use during the COVID-19 pandemic: A systematic review	188
Alcohol use and mental health during COVID-19 lockdown: A cross-sectional study in a sample of UK adults	152
Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis	121
Steep increases in fentanyl-related mortality west of the Mississippi River: Recent evidence from county and state surveillance	99
Factors associated with drinking behaviour during COVID-19 social distancing and lockdown among adults in the UK	99
Adverse childhood experiences (ACEs) and substance use disorder (SUD): A scoping review	93
Socioeconomic marginalization and opioid-related overdose: A systematic review	89
The early impact of COVID-19 on the incidence, prevalence, and severity of alcohol use and other drugs: A systematic review	87
Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users	83
The role of stigma in U.S. primary care physicians’ treatment of opioid use disorder	74
Fentanyl and fentanyl analogs in the illicit stimulant supply: Results from U.S. drug seizure data, 2011–2016	73
Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study	73
Non-pharmacological interventions for methamphetamine use disorder: a systematic review	73
Contingency management for the treatment of methamphetamine use disorder: A systematic review	72
Emotion regulation and substance use: A meta-analysis	65
Evaluating the impact of COVID-19: A cohort comparison study of drug use and risky sexual behavior among sexual minority men in the U.S.A.	65
Alcohol and marijuana co-use: Consequences, subjective intoxication, and the operationalization of simultaneous use	63
Trends in LSD use among US adults: 2015–2018	63
Patterns of substance use among adolescents: A systematic review	61
Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective	61
Substance use patterns and health profiles among US adults who use opioids, methamphetamine, or both, 2015-2018	60
Trends in seizures of powders and pills containing illicit fentanyl in the United States, 2018 through 2021	60
The relationship between incarceration history and overdose in North America: A scoping review of the evidence	59

Socially-supportive norms and mutual aid of people who use opioids: An analysis of Reddit during the initial COVID-19 pandemic	59
Current reporting of usability and impact of mHealth interventions for substance use disorder: A systematic review	59
The intersection of gender and drug use-related stigma: A mixed methods systematic review and synthesis of the literature	56
Cocaine use and overdose mortality in the United States: Evidence from two national data sources, 2002–2018	56
Prevalence and modes of cannabis use among youth in Canada, England, and the US, 2017 to 2019	54
Protracted renal clearance of fentanyl in persons with opioid use disorder	52
The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study	51
Transition from injecting opioids to smoking fentanyl in San Francisco, California	51
Drug overdose deaths involving cocaine and psychostimulants with abuse potential among racial and ethnic groups – United States, 2004–2019	49
Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden	48
Trends in characteristics of individuals who use methamphetamine in the United States, 2015-2018	48
Addressing opioid overdose deaths: The vision for the HEALing communities study	47
Detecting fentanyl using point-of-care drug checking technologies: A validation study	46
Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis	46
Adolescent drug use before and during U.S. national COVID-19 social distancing policies	45
Identifying individuals with opioid use disorder: Validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse	45
The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda	44
Anabolic androgenic steroids, antisocial personality traits, aggression and violence	44
The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an inte	43
Barriers and facilitators to a novel low-barrier hydromorphone distribution program in Vancouver, Canada: a qualitative study	42
Growing racial/ethnic disparities in buprenorphine distribution in the United States, 2007-2017	41
Opioid-related overdose mortality in the era of fentanyl: Monitoring a shifting epidemic by person, place, and time	41
Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder	40
The health and social consequences during the initial period of the COVID-19 pandemic among current and former people who inject drugs: A rapid phone survey in Baltimore, Maryland	40
Health communication campaigns to drive demand for evidence-based practices and reduce stigma in the HEALing communities study	40
Joint perceptions of the risk and availability of Cannabis in the United States, 2002-2018	40
A randomized controlled trial of a therapeutic relational agent for reducing substance misuse during the COVID-19 pandemic	40
Imprecise action selection in substance use disorder: Evidence for active learning impairments when solving the explore-exploit dilemma	40
Impact of state-level cannabis legalization on poly use of alcohol and cannabis in the United States, 2004–2017	40
Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty — United States, 2014–2019	39
Geographic proximity to buprenorphine treatment providers in the U.S.	39
A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders	39
Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence	38
Racial/ethnic differences in prescription opioid misuse and heroin use among a national sample, 1999–2018	38
Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to use	38
On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphine	38
Community engagement to implement evidence-based practices in the HEALing communities study	37
Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients’ experiences in Australia	37
Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use	37
Causal relationships between substance use and insomnia	36
Using machine learning for real-time BAC estimation from a new-generation transdermal biosensor in the laboratory	35
Associations between vaping and Covid-19: Cross-sectional findings from the HEBECO study	35
The continued rise of methamphetamine use among people who use heroin in the United States	35
The prevalence, child characteristics, and maternal risk factors for the continuum of fetal alcohol spectrum disorders: A sixth population-based study in the same South African community	35
Alcohol and substance use in pregnancy during the COVID-19 pandemic	34
Conceptualizing stigma in contexts of pregnancy and opioid misuse: A qualitative study with women and healthcare providers in Ohio	34
Prevalence and charges of opioid-related visits to U.S. emergency departments	34
A systematic review of opioid overdose interventions delivered within emergency departments	34
Buprenorphine prescription dispensing rates and characteristics following federal changes in prescribing policy, 2017-2018: A cross-sectional study	34
Is craving a risk factor for substance use among treatment-seeking individuals with alcohol and other drugs use disorders? A meta-analytic review	33

The naloxone delivery cascade: Identifying disparities in access to naloxone among people who inject drugs in Los Angeles and San Francisco, CA	33
Prevalence of mental disorders among people with opioid use disorder: A systematic review and meta-analysis	33
Prenatal exposure to methadone or buprenorphine impairs cognitive performance in young adult rats	32
“I felt like I had a scarlet letter”: Recurring experiences of structural stigma surrounding opioid tapers among patients with chronic, non-cancer pain	32
Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington	32
Quantity and frequency of cannabis use in relation to cannabis-use disorder and cannabis-related problems	32
Evaluation of an emergency safe supply drugs and managed alcohol program in COVID-19 isolation hotel shelters for people experiencing homelessness	32
Prevalence of childhood maltreatment among people with opioid use disorder: A systematic review and meta-analysis	31
Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder	31
Effects of multiple adverse childhood experiences on substance use in young adults: A review of the literature	31
Transgender-related discrimination and substance use, substance use disorder diagnosis and treatment history among transgender adults	31
Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs	31
Genomic relationships across psychiatric disorders including substance use disorders	30
LSD use in the United States: Trends, correlates, and a typology of us	30
Longitudinal associations with alcohol consumption during the first COVID-19 lockdown: Associations with mood, drinking motives, context of drinking, and mental health	30
The cost of opioid use disorder and the value of aversion	30
Comparing actual and forecasted numbers of unique patients dispensed select medications for opioid use disorder, opioid overdose reversal, and mental health, during the COVID-19 pandemic, United State	30
Substance use disorders and risk of severe maternal morbidity in the United States	29
Knowledge, preparedness, and compassion fatigue among law enforcement officers who respond to opioid overdose	29
Assessing alcohol consumption through wastewater-based epidemiology: Spain as a case study	29
Trust in a COVID-19 vaccine among people with substance use disorders	29
The Association between Opioid Discontinuation and Heroin Use: A Nested Case-Control Study	29
Cannabis use during pregnancy in the United States: The role of depression	29
Association of transphobic discrimination and alcohol misuse among transgender adults: Results from the U.S. Transgender Survey	28
Drug checking identifies counterfeit alprazolam tablets	28
Cross-fading motives for simultaneous alcohol and marijuana use: Associations with young adults’ use and consequences across days	28
Opioid use disorder treatment for people experiencing homelessness: A scoping review	28
Marijuana, but not alcohol, use frequency associated with greater loneliness, psychological distress, and less flourishing among young adults	28
Shifts in drug seizures in the United States during the COVID-19 pandemic	28
LGBTQ state policies: A lever for reducing SGM youth substance use and bullying	28
Results from a mobile drug checking pilot program using three technologies in Chicago, IL, USA	28
Frequency of cannabis use during pregnancy and adverse infant outcomes, by cigarette smoking status – 8 PRAMS states, 2017	28
The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD	28
“It’s not just injecting drugs”: Supervised consumption sites and the social determinants of health	27
Links between suicidal intent, polysubstance use, and medical treatment after non-fatal opioid overdose	27
Racial/ethnic differences in opioid-involved overdose deaths across metropolitan and non-metropolitan areas in the United States, 1999−2017	27
Substance use improvement depends on Race/Ethnicity: Outpatient treatment disparities observed in a large US national sample	27
Racial/ethnic disparities in the use of medications for opioid use disorder (MOUD) and their effects on residential drug treatment outcomes in the US	27
Nicotine formulations impact reinforcement-related behaviors in a mouse model of vapor self-administration	27
Effectiveness of the use of implementation intentions on reduction of substance use: A meta-analysis	26
Legality of drug checking equipment in the United States: A systematic legal analysis	26
Characteristics and correlates of U.S. clinicians prescribing buprenorphine for opioid use disorder treatment using expanded authorities during the COVID-19 pandemic	26
How prescription drug monitoring programs influence clinical decision-making: A mixed methods systematic review and meta-analysis	26
Predictive validity of the adult tobacco dependence index: Findings from waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) study	26
How much and how fast: Alcohol consumption patterns, drinking-episode affect, and next-day consequences in the daily life of underage heavy drinkers	26
Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort	25
Overdose deaths involving psychostimulants with abuse potential, excluding cocaine: State-level differences and the role of opioids	25
Prevalence of substance use and substance-related disorders among US Veterans Health Administration patients	25
Community dashboards to support data-informed decision-making in the HEALing communities study	25
Systematic review and meta-analysis of socio-cognitive and socio-affective processes association with adolescent substance use	25
The state of the science in opioid policy research	25
Structural and functional brain recovery in individuals with substance use disorders during abstinence: A review of longitudinal neuroimaging studies	24
Opioid overdose death following criminal justice involvement: Linking statewide corrections and hospital databases to detect individuals at highest risk	24
Pregnant people’s experiences discussing their cannabis use with prenatal care providers in a state with legalized cannabis	24
Cannabis-related diagnosis in pregnancy and adverse maternal and infant outcomes	24
Perceived risk, attitudes, and behavior of cigarette smokers and nicotine vapers receiving buprenorphine treatment for opioid use disorder during the COVID-19 pandemic	24
Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study	24
Changes in alcohol use since the onset of COVID-19 are associated with psychological distress among sexual and gender minority university students in the U.S	23
Addressing long overdue social and structural determinants of the opioid epidemic	23
Adolescent nicotine and marijuana vaping activity and the use of other illicit substances	23
Healthcare stigma and HIV risk among rural people who inject drugs	23
Frequent teenage cannabis use: Prevalence across adolescence and associations with young adult psychopathology and functional well-being in an urban cohort	23
Adolescent treatment admissions for marijuana following recreational legalization in Colorado and Washington	23
Using ICD-10-CM codes to detect illicit substance use: A comparison with retrospective self-report	23
Model and approach for assessing implementation context and fidelity in the HEALing Communities Study	23
COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs	23
Treatment provider perceptions of take-home methadone regulation before and during COVID-19	23
Use frequency and symptoms of nicotine dependence among adolescent E-cigarette users: Comparison of JUUL and Non-JUUL users	23
Identifying risk-thresholds for the association between frequency of cannabis use and development of cannabis use disorder: A systematic review and meta-analysis	23
Adherence to buprenorphine: An analysis of prescription drug monitoring program data	23
Use of telemedicine for opioid use disorder treatment – Perceptions and experiences of opioid use disorder clinicians	23
A pilot feasibility study of a behavioral intervention for nicotine vaping cessation among young adults delivered via telehealth	22
Gender differences in driving control of young alcohol-impaired drivers	22
Quit ratios for cigarette smoking among individuals with opioid misuse and opioid use disorder in the United States	22
Impact of cannabis legalization in the United States on trends in cannabis use and daily cannabis use among individuals who smoke cigarettes	22
Trends in U.S. women’s binge drinking in middle adulthood by socioeconomic status, 2006–2018	22
Mental and physical health in family members of substance users: A scoping review	22
Inpatient link to peer recovery coaching: Results from a pilot randomized control trial	22
Voluntary wheel running protects against the increase in ethanol consumption induced by social stress in mice	22
Recent trends and associated factors of amphetamine-type stimulant overdoses in emergency departments	21

Gender, employment, and continuous pandemic as predictors of alcohol and drug consumption during the COVID-19	21
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 U.S. states	21
Agreement between DSM-5 and DSM-IV measures of substance use disorders in a sample of adult substance users	21
Prevalence and correlates of ever having a substance use problem and substance use recovery status among adults in the United States, 2018	21
Impact of an unsanctioned safe consumption site on criminal activity, 2010–2019	21
Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020	21
COVID-19 survey among people who use drugs in three cities in Norway	21
Race, pain, and opioids among patients with chronic pain in a safety-net health system	21
Test-retest reliability of DSM-5 substance disorder measures as assessed with the PRISM-5, a clinician-administered diagnostic interview	21
Between- and within-group effects of alcohol and cannabis co-use on AUD/CUD in the NSDUH 2002–2019	21
Awareness, use and perceptions of cigarillos, heated tobacco products and nicotine pouches: A survey among Dutch adolescents and adults	21
Cross-country and historical variation in alcohol consumption among older men and women: Leveraging recently harmonized survey data in 21 countries	21
Review of sexualized drug use associated with sexually transmitted and blood-borne infections in gay, bisexual and other men who have sex with men	21
Overdose and risk factors for coronavirus disease 2019	21
Associations of alcohol use, mental health and socioeconomic status in England: Findings from a representative population survey	21
The use of person-centered language in scientific research articles focusing on alcohol use disorder	20
Evaluation of the rewarding effects of mitragynine and 7‐hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats	20
What is associated with the increased frequency of heavy episodic drinking during the COVID-19 pandemic? Data from the PAHO regional web-based survey	20
Primary care physicians’ preparedness to treat opioid use disorder in the United States: A cross-sectional survey	20
Changes in substance use in relation to opioid agonist therapy among people who use drugs in a Canadian setting	20
Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California’s prescription drug monitoring program	20
Impact of 12 step mutual help groups on drug use disorder patients across six clinical trials	20
Effects of fentanyl on acute locomotor activity, behavioral sensitization, and contextual reward in female and male rats	20
Tobacco use and tobacco services in California substance use treatment programs	20
Abuse liability assessment of the JUUL system in four flavors relative to combustible cigarette, nicotine gum and a comparator electronic nicotine delivery system among adult smokers	20
Exposure and engagement with tobacco-related social media and associations with subsequent tobacco use among young adults: A longitudinal analysis	20
Tobacco and marijuana co-use in a cohort of young adults: Patterns, correlates and reasons for co-use	20
Testing the drug use and condomless anal sex link among sexual minority men: The predictive utility of marijuana and interactions with relationship status	20
Estimating the contribution of stimulant injection to HIV and HCV epidemics among people who inject drugs and implications for harm reduction: A modeling analysis	20
Minority stress and drug use among transgender and gender diverse adults: A daily diary study	20
The impact of the national stay-at-home order on emergency department visits for suspected opioid overdose during the first wave of the COVID-19 pandemic	20
Utilizing telemedicine during COVID-19 pandemic for a low-threshold, street-based buprenorphine program	20
Barriers and facilitators to PDMP IS Success in the US: A systematic review	20
Liver injury associated with kratom, a popular opioid-like product: Experience from the U.S. drug induced liver injury network and a review of the literature	19
Canada’s cannabis legalization and drivers’ traffic-injury presentations to emergency departments in Ontario and Alberta, 2015-2019	19
Inpatient addiction consultation and post-discharge 30-day acute care utilization	19
Cannabis use among US adults with anxiety from 2008 to 2017: The role of state-level cannabis legalization	19
Harm reduction outcomes and practices in Housing First: A mixed-methods systematic review	19
Digital media use and subsequent cannabis and tobacco product use initiation among adolescents	19
Measurement invariance and psychometric properties of Perceived Stigma toward People who use Substances (PSPS) among three types of substance use disorders: Heroin, amphetamine, and alcohol	19
Incidence and treatment costs of severe bacterial infections among people who inject heroin: A cohort study in South London, England	19
Alcohol expectancies change in early to middle adolescence as a function of the exposure to parental alcohol use	19
Cannabis legalization and cannabis use, daily cannabis use and cannabis-related problems among adults in Ontario, Canada (2001–2019)	19
Retail availability and legal purchases of dried flower in Canada post-legalization	19
Effectiveness of peer recovery support services on stages of the opioid use disorder treatment cascade: A systematic review	19
Estimating the community prevalence, child traits, and maternal risk factors of fetal alcohol spectrum disorders (FASD) from a random sample of school children	19
Do out-of-pocket costs influence retention and adherence to medications for opioid use disorder?	19
Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws	19
Implementation and enforcement of state opioid prescribing laws	19
Prevalence of new psychoactive substances (NPS) in Brazil based on oral fluid analysis of samples collected at electronic music festivals and parties	18
Trends and characteristics of cannabis-associated emergency department visits in the United States, 2006–2018	18
Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments	18
Robustness of estimated access to opioid use disorder treatment providers in rural vs. urban areas of the United States	18
Relations between impulsive personality traits, alcohol and cannabis co-use, and negative alcohol consequences: A test of cognitive and behavioral mediators	18
Prevalence and minority-stress correlates of past 12-month prescription drug misuse in a national sample of transgender and gender nonbinary adults: Results from the U.S. Transgender Survey	18
Prospective associations of e-cigarette use with cigarette, alcohol, marijuana, and nonmedical prescription drug use among US adolescents	18
Prevalence, risk and protective factors of alcohol use disorder during the COVID-19 pandemic in U.S. military veterans	18
Listed for sale: Analyzing data on fentanyl, fentanyl analogs and other novel synthetic opioids on one cryptomarket	18
Syndemic latent transition analysis in the HPTN 061 cohort: Prospective interactions between trauma, mental health, social support, and substance use	18
Racial/ethnic discrimination and alcohol use disorder severity among United States adults	18
Explication of CB1 receptor contributions to the hypothermic effects of Δ9-tetrahydrocannabinol (THC) when delivered by vapor inhalation or parenteral injection in rats	18
Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial	18
Substance use patterns in 9-10 year olds: Baseline findings from the adolescent brain cognitive development (ABCD) study	18
Psychosocial and health problems associated with alcohol use disorder and cannabis use disorder in U.S. adults	18
The impact of COVID-19 on opioid treatment programs in the United States	18
Victim and perpetrator characteristics in alcohol/drug-involved sexual violence victimization in the U.S	18
Quarterly trends in past-month cannabis use in the United States, 2015-2019	18
Trajectories of alcohol use and problems during the COVID-19 pandemic: The role of social stressors and drinking motives for men and women	18
Structural racism and violence as social determinants of health: Conceptual, methodological and intervention challenges	18
Predictors of Opioid Misuse During Emerging Adulthood: An Examination of Adolescent Individual, Family and Peer Factors	17
Effect of alcohol interventions on suicidal ideation and behaviour: A systematic review and meta-analysis	17
Genome-wide association analysis of opioid use disorder: A novel approach using clinical data	17
Polysubstance use among youth experiencing homelessness: The role of trauma, mental health, and social network composition	17
The impact of menthol flavoring in combusted tobacco on alternative product purchasing: A pilot study using the Experimental Tobacco Marketplace	17
Variability in the unregulated opioid market in the context of extreme rates of overdose	17
Evaluation of an emergency department-based opioid overdose survivor intervention: Difference-in-difference analysis of electronic health record data to assess key outcomes	17
Socio-ecological and pharmacy-level factors associated with naloxone stocking at standing-order naloxone pharmacies in New York City	17
Adjunct interventions to standard medical management of buprenorphine in outpatient settings: A systematic review of the evidence	17
Sexual minority tobacco use disparities across adolescence and the transition to young adulthood	17
Cannabis use and misuse in the year following recreational cannabis legalization in Canada: A longitudinal observational cohort study of community adults in Ontario	17
Medications for opioid use disorder among American Indians and Alaska natives: Availability and use across a national sample	17
Factors associated with skin and soft tissue infections among people who inject drugs in the United Kingdom: A comparative examination of data from two surveys	17
A synthetic opioid vaccine attenuates fentanyl-vs-food choice in male and female rhesus monkeys	17
Association between observing peers vaping on campus and E-cigarette use and susceptibility in middle and high school students	17
Impact of medications for opioid use disorder among persons hospitalized for drug use-associated skin and soft tissue infections	17
Smoking and cessation treatment among persons with and without HIV in a U.S. integrated health system	17
Motivations for opioid and stimulant use among drug using black sexual minority men: A life course perspective	17
Contrasting effects of adolescent and early-adult ethanol exposure on prelimbic cortical pyramidal neurons	17
Sociodemographic changes in emergency department visits due to alcohol during COVID-19	17
Effects of acute exercise on craving, mood and anxiety in non-treatment seeking adults with alcohol use disorder: An exploratory study	17
Knowledge, attitudes, and prescribing patterns of cannabis and cannabinoid-containing medicines among European healthcare workers: a systematic literature review	17
Nicotine dependence symptoms in U.S. youth who use JUUL E-cigarettes	17
Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder	17
Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: Results from a multisite trial of buprenorphine-naloxone and methadone	17
Medical provider stigma experienced by people who use drugs (MPS-PWUD): Development and validation of a scale among people who currently inject drugs in New York City	17